TE Connectivity Opens 1st Global Medical Device Prototyping Center

TE Connectivity Corporation, a world leader in connectors and sensors, has opened its global Propelus Prototype Center for medical devices at its existing manufacturing site in Galway, Ireland.

The $5 million rapid prototyping center directly connects TE engineers with customers to reduce development time and increase speed to market for lifesaving and life-improving medical devices.

With more than 120 patients treated every minute with a medical device containing TE Connectivity technology, TE’s Galway site fulfills close to the complete global demand for minimally invasive catheter metal shafts, such as coronary stents used to open clogged heart arteries and neurovascular coils which are used in the treatment of brain aneurysms.

The Propelus Prototype Center features advanced engineering capabilities, including build-to-print services, quick turnaround prototype production and 3D printing. TE engineers work alongside customers to quickly make customer concepts a reality, enabling them to visit and leave with a physical, functional prototype, along with a detailed commercialization proposal. TE Connectivity can also manufacture the customer’s final device at high volumes in one of TE’s global manufacturing facilities and help manage their supply chain.

Commenting on the launch of the Propelus Prototype Center, Director of Operations Mark Gill said: “The principle is simple – getting high quality prototypes into customers’ hands as quickly as possible. By improving the speed of product development and manufacturing, TE will help customers innovate and iterate advanced treatments at a more efficient pace, ultimately transforming patient care for the better.”

“When our Propelus Prototype Center engineers are not busy working on customer projects, they are innovating for the future, staying close to new therapies, and trialing new technologies so we stay ahead of the curve, today and tomorrow.”

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.